• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用自体表皮移植治疗交界性大疱性表皮松解症。

Treatment of junctional epidermolysis bullosa with epidermal autografts.

作者信息

Carter D M, Lin A N, Varghese M C, Caldwell D, Pratt L A, Eisinger M

出版信息

J Am Acad Dermatol. 1987 Aug;17(2 Pt 1):246-50. doi: 10.1016/s0190-9622(87)70199-6.

DOI:10.1016/s0190-9622(87)70199-6
PMID:3114337
Abstract

We have successfully treated chronic facial erosions in three boys with junctional epidermolysis bullosa. In each patient, keratinocytes were harvested from the roof of suction blisters created on clinically uninvolved skin. They were grown in tissue culture on collagen sponges and grafted onto facial erosions that were previously treated with 2% mupirocin ointment. This experimental antibiotic ointment has proved efficacy in eradicating cutaneous pathogens such as Staphylococcus aureus from chronic wounds. In two patients, complete reepithelialization was achieved over 7 and 10 months, respectively, and partial reepithelialization occurred in another patient in whom treatment is ongoing. Epidermal autografts are a promising means for improving function and appearance in eroded skin caused by junctional epidermolysis bullosa.

摘要

我们成功治疗了三名患有交界性大疱性表皮松解症的男孩的慢性面部糜烂。在每位患者身上,从临床未受累皮肤产生的抽吸水疱顶部采集角质形成细胞。将它们在胶原海绵上进行组织培养,并移植到先前用2%莫匹罗星软膏治疗过的面部糜烂处。这种实验性抗生素软膏已被证明在根除慢性伤口中的皮肤病原体如金黄色葡萄球菌方面有效。在两名患者中,分别在7个月和10个月实现了完全上皮再生,另一名正在接受治疗的患者发生了部分上皮再生。自体表皮移植是改善交界性大疱性表皮松解症所致糜烂皮肤功能和外观的一种有前景的方法。

相似文献

1
Treatment of junctional epidermolysis bullosa with epidermal autografts.采用自体表皮移植治疗交界性大疱性表皮松解症。
J Am Acad Dermatol. 1987 Aug;17(2 Pt 1):246-50. doi: 10.1016/s0190-9622(87)70199-6.
2
Wound healing and epidermolysis bullosa.
Arch Dermatol. 1988 May;124(5):732-3.
3
Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa.大疱性表皮松解症患者长期治疗后出现的耐莫匹罗星金黄色葡萄球菌
J Am Acad Dermatol. 1990 May;22(5 Pt 1):893-5. doi: 10.1016/0190-9622(90)70120-7.
4
Treatment of chronic erosions of junctional epidermolysis bullosa with human epidermal allografts.
J Dermatol Surg Oncol. 1992 May;18(5):396-400. doi: 10.1111/j.1524-4725.1992.tb03692.x.
5
Pretibial epidermolysis bullosa. Successful therapy with a skin graft.胫前大疱性表皮松解症。皮肤移植治疗成功。
Arch Dermatol. 1986 Mar;122(3):310-3. doi: 10.1001/archderm.122.3.310.
6
Death from metastatic, cutaneous, squamous cell carcinoma in autosomal recessive dystrophic epidermolysis bullosa despite permanent inpatient care.
Dermatologica. 1988;177(3):180-4. doi: 10.1159/000248539.
7
Cultured autologous keratinocyte grafting of chronic erosions in three patients with epidermolysis bullosa.三例大疱性表皮松解症患者慢性糜烂创面的自体培养角质形成细胞移植术
Clin Exp Dermatol. 2006 Sep;31(5):718-9. doi: 10.1111/j.1365-2230.2006.02200.x.
8
Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes database.大疱性表皮松解症伤口微生物的特征:来自大疱性表皮松解症临床特征与结局数据库的结果
Pediatr Dermatol. 2021 Jan;38(1):119-124. doi: 10.1111/pde.14444. Epub 2020 Nov 28.
9
Pyoderma pathophysiology and management.脓疱病的病理生理学与治疗
Arch Dermatol. 1988 May;124(5):753-5.
10
Cicatricial junctional epidermolysis bullosa.
J Am Acad Dermatol. 1985 May;12(5 Pt 1):836-44. doi: 10.1016/s0190-9622(85)70105-3.

引用本文的文献

1
Gene-edited cells: novel allogeneic gene/cell therapy for epidermolysis bullosa.基因编辑细胞:用于大疱性表皮松解症的新型异基因基因/细胞疗法。
J Appl Genet. 2024 Dec;65(4):705-726. doi: 10.1007/s13353-024-00839-2. Epub 2024 Mar 9.
2
Emerging Gene Therapeutics for Epidermolysis Bullosa under Development.正在开发中的新型基因疗法治疗大疱性表皮松解症。
Int J Mol Sci. 2024 Feb 13;25(4):2243. doi: 10.3390/ijms25042243.
3
Greener Grass: The Modern History of Epithelial Stem Cell Innovation.更绿的草地:上皮干细胞创新的现代史
Life (Basel). 2023 Mar 3;13(3):688. doi: 10.3390/life13030688.
4
Modified Non-Cultured Cell Spray Induced Epithelization in LAMB3 Mutation Epidermolysis Bullosa.改良的非培养细胞喷雾诱导LAMB3突变型大疱性表皮松解症上皮形成
Clin Cosmet Investig Dermatol. 2022 Oct 14;15:2197-2202. doi: 10.2147/CCID.S377753. eCollection 2022.
5
Epidermolysis Bullosa: A Review of the Tissue-Engineered Skin Substitutes Used to Treat Wounds.大疱性表皮松解症:用于治疗创面的组织工程皮肤替代物的综述。
Mol Diagn Ther. 2022 Nov;26(6):627-643. doi: 10.1007/s40291-022-00613-2. Epub 2022 Oct 17.
6
Investigational Treatments for Epidermolysis Bullosa.表皮松解性水疱症的治疗研究。
Am J Clin Dermatol. 2021 Nov;22(6):801-817. doi: 10.1007/s40257-021-00626-3. Epub 2021 Jul 22.
7
Leading edge: emerging drug, cell, and gene therapies for junctional epidermolysis bullosa.前沿:用于交界型大疱性表皮松解症的新兴药物、细胞和基因疗法。
Expert Opin Biol Ther. 2020 Aug;20(8):911-923. doi: 10.1080/14712598.2020.1740678. Epub 2020 Mar 20.
8
Synthetic polymeric biomaterials for wound healing: a review.用于伤口愈合的合成高分子生物材料:综述
Prog Biomater. 2018 Mar;7(1):1-21. doi: 10.1007/s40204-018-0083-4. Epub 2018 Feb 14.
9
Skin substitutes: an overview of the key players in wound management.皮肤替代品:伤口管理中的关键参与者概述。
J Clin Aesthet Dermatol. 2014 Oct;7(10):44-8.
10
Cell therapy in dermatology.皮肤科中的细胞疗法。
Cold Spring Harb Perspect Med. 2014 Jun 2;4(6):a015156. doi: 10.1101/cshperspect.a015156.